Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

1.

PWE-168 Is There A Relationship Between Irritable Bowel Syndrome Symptoms And Small Bowel Bacterial Overgrowth?

Hayman J, Pickering G, Sanders D.

Gut. 2014 Jun;63(Suppl 1):A198-A199. doi: 10.1136/gutjnl-2014-307263.428.

PMID:
25021661
[PubMed - as supplied by publisher]
2.

Breath tests and irritable bowel syndrome.

Rana SV, Malik A.

World J Gastroenterol. 2014 Jun 28;20(24):7587-7601. Review.

PMID:
24976698
[PubMed - as supplied by publisher]
Free PMC Article
3.

[Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].

Łokieć K, Klupińska G, Walecka-Kapica E, Błońska A.

Pol Merkur Lekarski. 2014 May;36(215):307-10. Polish.

PMID:
24964506
[PubMed - in process]
4.

Symptomatic fructose malabsorption in irritable bowel syndrome: A prospective study.

Melchior C, Gourcerol G, Déchelotte P, Leroi AM, Ducrotté P.

United European Gastroenterol J. 2014 Apr;2(2):131-7. doi: 10.1177/2050640614521124.

PMID:
24918018
[PubMed]
Free PMC Article
5.

Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.

Chedid V, Dhalla S, Clarke JO, Roland BC, Dunbar KB, Koh J, Justino E, Tomakin E, Mullin GE.

Glob Adv Health Med. 2014 May;3(3):16-24. doi: 10.7453/gahmj.2014.019.

PMID:
24891990
[PubMed]
6.

[Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: An evidence-based review].

Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA.

Rev Gastroenterol Mex. 2014 Apr-Jun;79(2):96-134. doi: 10.1016/j.rgmx.2014.01.004. Epub 2014 May 23. Spanish.

PMID:
24857420
[PubMed - in process]
7.

Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.

Ghoshal UC, Srivastava D, Ghoshal U, Misra A.

Eur J Gastroenterol Hepatol. 2014 Jul;26(7):753-60. doi: 10.1097/MEG.0000000000000122.

PMID:
24849768
[PubMed - in process]
8.

Unclear abdominal discomfort: pivotal role of carbohydrate malabsorption.

Goebel-Stengel M, Stengel A, Schmidtmann M, Voort Iv, Kobelt P, Mönnikes H.

J Neurogastroenterol Motil. 2014 Apr 30;20(2):228-35. doi: 10.5056/jnm.2014.20.2.228.

PMID:
24840375
[PubMed]
Free PMC Article
9.

A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.

Zhao J, Zheng X, Chu H, Zhao J, Cong Y, Fried M, Fox M, Dai N.

Neurogastroenterol Motil. 2014 Jun;26(6):794-802. doi: 10.1111/nmo.12331. Epub 2014 Mar 18.

PMID:
24641100
[PubMed - in process]
10.

Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.

Ghoshal UC, Srivastava D.

World J Gastroenterol. 2014 Mar 14;20(10):2482-91. doi: 10.3748/wjg.v20.i10.2482. Review.

PMID:
24627585
[PubMed - in process]
Free PMC Article
11.

Overgrowth of the indigenous gut microbiome and irritable bowel syndrome.

Bye W, Ishaq N, Bolin TD, Duncombe VM, Riordan SM.

World J Gastroenterol. 2014 Mar 14;20(10):2449-55. doi: 10.3748/wjg.v20.i10.2449. Review.

PMID:
24627582
[PubMed - in process]
Free PMC Article
12.

Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.

Moraru IG, Portincasa P, Moraru AG, Diculescu M, Dumitraşcu DL.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):143-7.

PMID:
24620626
[PubMed - indexed for MEDLINE]
13.

Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract--beyond the era of Helicobacter pylori.

Walker MM, Talley NJ.

Aliment Pharmacol Ther. 2014 Apr;39(8):767-79. doi: 10.1111/apt.12666. Epub 2014 Feb 24.

PMID:
24612362
[PubMed - in process]
14.

[Irritable bowel syndrome: a functional disorder?].

Man F, Bustos Fernández LM.

Acta Gastroenterol Latinoam. 2013 Dec;43(4):321-34. Review. Spanish. Erratum in: Acta Gastroenterol Latinoam. 2014 Mar;44(1):75.

PMID:
24516961
[PubMed - indexed for MEDLINE]
15.

Motility abnormalities in irritable bowel syndrome.

DuPont AW, Jiang ZD, Harold SA, Snyder N, Galler GW, Garcia-Torres F, DuPont HL.

Digestion. 2014;89(2):119-23. doi: 10.1159/000356314. Epub 2014 Feb 6.

PMID:
24503633
[PubMed - in process]
16.

In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth.

Pistiki A, Galani I, Pyleris E, Barbatzas C, Pimentel M, Giamarellos-Bourboulis EJ.

Int J Antimicrob Agents. 2014 Mar;43(3):236-41. doi: 10.1016/j.ijantimicag.2013.12.008. Epub 2014 Jan 6.

PMID:
24461710
[PubMed - in process]
17.

Small intestinal bacterial overgrowth: what it is and what it is not.

Quigley EM.

Curr Opin Gastroenterol. 2014 Mar;30(2):141-6. doi: 10.1097/MOG.0000000000000040.

PMID:
24406476
[PubMed - in process]
18.

[The composition of the gastrointestinal mucosa-associated microbiota in irritable bowel syndrome patients].

Loranskaia ID, Boldyreva MN, Lavrent'eva OA.

Eksp Klin Gastroenterol. 2013;(3):15-22. Russian.

PMID:
24294767
[PubMed - indexed for MEDLINE]
19.

Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.

Thompson A, Meah D, Ahmed N, Conniff-Jenkins R, Chileshe E, Phillips CO, Claypole TC, Forman DW, Row PE.

BMC Complement Altern Med. 2013 Nov 28;13:338. doi: 10.1186/1472-6882-13-338.

PMID:
24283351
[PubMed - indexed for MEDLINE]
Free Article
20.

Role of PHGG as a dietary fiber: a review article.

Quartarone G.

Minerva Gastroenterol Dietol. 2013 Dec;59(4):329-40. Review.

PMID:
24212352
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk